U.S. markets open in 3 hours 25 minutes
  • S&P Futures

    4,249.25
    +3.50 (+0.08%)
     
  • Dow Futures

    34,480.00
    +18.00 (+0.05%)
     
  • Nasdaq Futures

    14,028.75
    +34.50 (+0.25%)
     
  • Russell 2000 Futures

    2,329.60
    -0.90 (-0.04%)
     
  • Crude Oil

    71.46
    +0.55 (+0.78%)
     
  • Gold

    1,859.70
    -19.90 (-1.06%)
     
  • Silver

    27.86
    -0.29 (-1.02%)
     
  • EUR/USD

    1.2120
    +0.0013 (+0.11%)
     
  • 10-Yr Bond

    1.4620
    0.0000 (0.00%)
     
  • Vix

    15.92
    -0.18 (-1.12%)
     
  • GBP/USD

    1.4092
    -0.0025 (-0.17%)
     
  • USD/JPY

    109.6900
    +0.0550 (+0.05%)
     
  • BTC-USD

    39,182.93
    +3,404.14 (+9.51%)
     
  • CMC Crypto 200

    975.25
    +33.43 (+3.55%)
     
  • FTSE 100

    7,166.68
    +32.62 (+0.46%)
     
  • Nikkei 225

    29,161.80
    +213.07 (+0.74%)
     

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SOS, KRMD and ACAD

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / May 12, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

SOS Limited (NYSE:SOS)
Class Period: July 22, 2020 - February 25, 2021
Lead Plaintiff Deadline: June 1, 2021

The SOS lawsuit alleges that SOS Limited made materially false and/or misleading statements and/or failed to disclose that: (i) SOS had misrepresented the true nature, location, and/or existence of at least one of the principal executive offices listed in its SEC filings; (ii) HY and FXK were either undisclosed related parties and/or entities fabricated by the Company; (iii) the Company had misrepresented the type and/or existence of the mining rigs that it claimed to have purchased; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in SOS: http://www.kleinstocklaw.com/pslra-1/sos-limited-loss-submission-form?id=15753&from=1

Repro Med Systems, Inc. (NASDAQ:KRMD)
Class Period: August 4, 2020 - January 25, 2021
Lead Plaintiff Deadline: May 25, 2021

The KRMD lawsuit alleges Repro Med Systems, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) starting in January 2020, Repro Med Systems ramped up the use of allowances, including growth rebates, to retain key customers and to incentivize growth; (2) as the rebates accrued, the Company's net sales were reasonably likely to decline; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in KRMD: http://www.kleinstocklaw.com/pslra-1/repro-med-systems-inc-loss-submission-form?id=15753&from=1

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD)
Class Period: June 15, 2020 - April 4, 2021
Lead Plaintiff Deadline: June 18, 2021

The ACAD lawsuit alleges that throughout the class period, Acadia Pharmaceuticals Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the materials submitted in support of the pimavanserin sNDA contained statistical and design deficiencies; (ii) accordingly, the pimavanserin sNDA lacked the evidentiary support that the Company had led investors to believe it possessed; (iii) the FDA was unlikely to approve the pimavanserin sNDA in its present form; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in ACAD: http://www.kleinstocklaw.com/pslra-1/acadia-pharmaceuticals-inc-loss-submission-form?id=15753&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm



View source version on accesswire.com:
https://www.accesswire.com/646813/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-SOS-KRMD-and-ACAD